AI Meets Molecular Biology, Genetic Oncology and Pharmacogenomics
Periculum is proud to introduce our interdisciplinary research and development endeavor that bridges AI with molecular biology, genetic oncology, and pharmacology. Through studies at the molecular and multiomics levels, we are exploring how deep learning and generative AI can enable more precise genomic profiling, characterize mutation effects, and unlock preventive therapies for breast and cervical cancers before they form. This convergence will enable us to introduce scalable, personalized AI solutions for precision oncology and preventive cancer care.
